1. Rechziegler H, Zundorf P (1985) Acemetacin in the treatment of rheumatic diseases: an open, multicentre trial. Curr Med Res Opin 9:701–707
2. Li DM, Lu WL, Wang XQ, Wang JC, Zhang H, Zhang RJ, Wag GL, Zhang X, Zhang Q (2005) Pharmacokinetics of indomethacin, a metabolite of acemetacin, following a single dose and multiple doses administered as acemetacin sustained-release tablets in healthy male volunteers. J Health Sci 52:308–316
3. Heiter A, Tausch G, Eberl R (1980) Results of a long-term study with acemetacin in the therapy of patients suffering from rheumatoid arthritis. Arzneimittelforschung 30:1460–1463
4. Lonauer G, Wirth W (1980) Controlled double blind study on the effectiveness and adverse effects of acemetacin and indomethacin in the treatment of psoriatic arthritis. Arzneimittelforschung 30:1440–1444
5. Peter E, Hartl PE (1982) Treatment of ankylosing spondylitis with acemetacin, a new nonsteroidal antirheumatic agent. Med Welt 33:1600–1606